Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.
about
Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targetingIL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysisMetabolic imbalance and prostate cancer progression.Association between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies.Association between tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis.Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients.Chemokine polymorphisms and lymphoma: a pooled analysisAssociation between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent: a case-control studyInflammatory genetic markers of prostate cancer risk.-2518 A/G MCP-1 but not -403 G/A RANTES gene polymorphism is associated with enhanced risk of basal cell carcinoma.Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort.RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.The possible role of the tumour necrosis factor polymorphisms and human leucocyte antigens in the development of prostate cancer.Significance of Tumor necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer.Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma.Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.Opposing effects of pro- and anti-inflammatory cytokine gene polymorphisms on the risk for breast cancer in western Indian women: a pilot study.
P2860
Q34010429-444BDFC2-508E-47D5-928F-63590288CBD3Q34523165-4EDD6B82-B111-433D-9A6F-35954927C960Q34794028-6BDCDE46-08EC-4DF3-8780-14A4A0399F0AQ35075456-651B6F81-BBA3-42C3-AF75-26A3A0E1C459Q35130586-8255129D-A2F2-4A7B-A9B5-55EA7580CE08Q35516448-0F8E3327-60A4-44CE-AED7-9F610ACCFEE9Q36046753-98ADE501-206B-4CFE-A512-0D568C816152Q36237839-A5A00ABE-C8C5-44AF-AD23-FBB3F26B9FDFQ36360813-9EDB9DBC-AF1F-45EC-A3A2-FA1BE70410DCQ36480538-D2C2D086-8439-4087-908D-B96F899EAE84Q37328413-A50E3DCB-AD14-41D1-AF96-D2C9EFAB0D70Q37416312-968470D8-98BF-4AC7-9E1A-C0F38380F8F5Q39419250-23775DED-16A5-4121-B1E1-8F8D8B936421Q42700287-C5D34635-BEEB-4FBF-A3E8-DF59AD86492CQ43809862-15E8BDB1-F642-499C-8A1E-8B3871DD268BQ47749007-8D081464-095B-4227-A08F-31C8A86A489CQ53117530-1C9F38C2-9036-4ED8-AE34-BFF5451E5407Q53263340-D1F76592-B48B-4AD0-96B2-F9D3B03B613EQ54397543-81ACA54B-942F-4FB3-8D05-92A109319FEFQ54404821-DDF7290D-5DEA-4142-B94D-23B318046161Q54687752-680E3021-AD4D-4BD5-8F03-1DCC53ABF8B1
P2860
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genetic polymorphisms of RANTE ...... patients with prostate cancer.
@ast
Genetic polymorphisms of RANTE ...... patients with prostate cancer.
@en
type
label
Genetic polymorphisms of RANTE ...... patients with prostate cancer.
@ast
Genetic polymorphisms of RANTE ...... patients with prostate cancer.
@en
prefLabel
Genetic polymorphisms of RANTE ...... patients with prostate cancer.
@ast
Genetic polymorphisms of RANTE ...... patients with prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Genetic polymorphisms of RANTE ...... patients with prostate cancer.
@en
P2093
Federico Garrido
Francisco Ruiz-Cabello
José Manuel Cózar
José Maria Romero
José Ramón Vilchez
Julia Canton
Miguel Tallada
Pablo Sáenz-López
Rafael Carretero
P2860
P2888
P356
10.1186/1471-2407-8-382
P407
P577
2008-12-19T00:00:00Z
P5875
P6179
1028989173